Barclays analyst Brandon Oglenski lowered the firm’s price target on RXO Inc. (RXO) to $17 from $18 and keeps an Overweight rating on the shares following the Q2 report. The company continues to make progress in operation expense and purchased transportation synergies, but a “tepid” freight market, reduced throughput in automotive end markets and limited spot market opportunities will likely limit earnings upside in the second half of 2025, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXO:
- RXO Inc. price target raised to $16 from $15 at TD Cowen
- RXO Inc. price target raised to $15 from $14 at UBS
- RXO, Inc.: Hold Rating Maintained Amid Stable Outlook and Modest Growth Expectations
- RXO, Inc.: Balancing Profitability Amid Market Challenges with a Hold Rating
- RXO, Inc. Reports Strong Q2 Performance Amid Market Challenges